我要投票 瑞普ringpu在兽药行业中的票数:918
· 外 推 电 报 ·
2026-01-09 08:37:32 星期五

【瑞普ringpu是哪个国家的品牌?】

瑞普ringpu是什么牌子?「瑞普ringpu」是 天津瑞普生物技术股份有限公司 旗下著名品牌。该品牌发源于天津市,由创始人李守军在2001-08-02期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力瑞普ringpu品牌出海!将品牌入驻外推网,定制瑞普ringpu品牌推广信息,可以显著提高瑞普ringpu产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

创立于1998年,天津名牌产品,国内规模较大/产品种类齐全的动物保健品生产基地,专注于兽药领域的上市公司


瑞普生物,中国A股市场上一家专注于兽药领域的上市公司,瞄准国际生物技术和动物医学发展前沿,围绕农业可持续发展的国家需求,秉承“前瞻、创新、正直、 分享”的企业理念,用高品质的产品,正在为行业技术进步、养殖业健康发展和动物源性食品安全贡献着力量。

瑞普生物成立于1998年,创业十多年来,不断创新、开拓进取,已从单一企业成长为具有规模的动物保健产业集群。旗下拥有瑞普(天津)生物药业有限公司、瑞普(保定)生物药业有限公司、天津瑞普生物技术股份有限公司高科分公司、湖北龙翔药业有限公司、湖南中岸生物药业有限公司、内蒙古瑞普大地动物药业有限公司6个GMP生产基地,拥有原料药生产线、粉剂/散剂/预混剂、口服液生产线、消毒剂生产线、注射剂生产线、颗粒剂生产 线、片剂生产线、灭活疫苗生产线、活疫苗生产线等30条大型生产线。

瑞普生物不断开发和生产高质量和高附加值的产品。目前拥有家禽、家畜、宠物、水产等动物产品280多种,其中化学药物近170种,生物制品50多种,饲料添加剂30多种,植物提取制剂30多种。产品是人品、控制是诚信、质量是生命,瑞普生物信守质量承诺,坚持内控标准高于国家标准10%,产品质量抽检合格率连续11 年居行业前列,主要产品在多个细分市场名列前茅。良好的市场占有率和高品质的产品效果,让“瑞普”品牌获得了行业和客户的广泛认可。以创新的产品引导市场,以过硬的品质赢得市场,推进着动保行业可持续健康发展。


英文翻译:Founded in 1998, Tianjin is a famous brand product, a large-scale domestic animal health product production base with a complete range of products. It focuses on rip bio, a listed company in the field of veterinary medicine, a listed company in China's A-share market that focuses on the field of veterinary medicine. It aims at the forefront of international biotechnology and animal medicine development, focuses on the national demand for sustainable agricultural development, and adheres to the principle of "forward-looking and innovative" With high-quality products, the company is contributing to the technical progress of the industry, the healthy development of the breeding industry and the safety of animal derived food. Rip bio was founded in 1998. Since its establishment more than ten years ago, it has been continuously innovating and pioneering, and has grown from a single enterprise to a large-scale animal health industry cluster. It has 6 GMP production bases, i.e. Ruipu (Tianjin) biopharmaceutical Co., Ltd., Ruipu (Baoding) biopharmaceutical Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd. hi tech branch, Hubei Longxiang Pharmaceutical Co., Ltd., Hunan Zhongan biopharmaceutical Co., Ltd. and Inner Mongolia Ruipu Dadi Animal Pharmaceutical Co., Ltd., with API production line, powder / powder / premix There are 30 large-scale production lines including preparation, oral liquid production line, disinfectant production line, injection production line, granule production line, tablet production line, inactivated vaccine production line and live vaccine production line. Rip bio continues to develop and produce high quality and value-added products. At present, it has more than 280 kinds of animal products such as poultry, livestock, pets and aquatic products, including nearly 170 kinds of chemical drugs, 50 kinds of biological products, 30 kinds of feed additives and 30 kinds of plant extracts. Products are human quality, control is integrity, quality is life. Rip bio abides by its quality commitment, adheres to the internal control standard of 10% higher than the national standard. The qualified rate of product quality spot check ranks first in the industry for 11 consecutive years, and the main products rank first in many market segments. With a good market share and high quality product effect, "rip" brand has been widely recognized by the industry and customers. To guide the market with innovative products, win the market with excellent quality, and promote the sustainable and healthy development of the mobile insurance industry.

本文链接: https://www.waitui.com/brand/a3c115b2d.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

38分钟前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

38分钟前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

38分钟前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

38分钟前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

38分钟前

本页详细列出关于瑞普ringpu的品牌信息,含品牌所属公司介绍,瑞普ringpu所处行业的品牌地位及优势。
咨询